In a glioma model, FASN expression and lipid synthesis were high in patient-derived TICs, along with glioma TIC markers SOX2, fatty acid binding protein-2 (FABP2) and nestin, and FASN inhibition led to downregulation of these markers as well as decreased viability and invasivity [44]. This evidence concerns the gene FASN and glioma.